Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
J. D. de Bono,H. Scher,7 Authors,D. Raghavan
2008 · DOI: 10.1158/1078-0432.CCR-08-0872
Clinical Cancer Research · 1,969 Citations
TLDR
CTC are the most accurate and independent predictor of OS in CRPC, and this data led to Food and Drug Administration clearance of this assay for the evaluation of CRPC.